Abstract
Prothrombin time (PT) and/or International Normalized Ratio (INR) is the most commonly used coagulation assay in health care, to diagnose the risk of bleeding and to monitor oral anticoagulation therapy.
This test is based on the principle that in citrated plasma, the addition of a thromboplastin and CaCl2 allows for formation of a stable clot. The time required for the formation of a stable clot is recorded in seconds and represents the actual PT result. INR is calculated from the PT and allows for worldwide standardization of results.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Quick J (1935) The prothrombin time in haemophilia and in obstructive jaundice. J Biol Chem 109:74–74
Cohen AJ, Kessler CM (2002) Haemophilia A and B. In: Kitchens CS, Alving BM, Kessler CM (eds) Consultative hemostasis and thrombosis. WB Saunders, Philadelphia, pp 43–56
Roberts HR, Escobar MA (2002) Less common congenital disorders of hemostasis. In: Kitchen S, Alving BM, Kessler CM (eds) Consultative haemostasis and thrombosis. WB Saunders, Philadelphia, pp 57–71
Triplett DA (2002) Coagulation abnormalities. In: McClatchey KD (ed) Clinical laboratory medicine, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 1033–1049
Haemostasis (1985) ICSH/ISTH recommendations for reporting prothrombin time in oral anticoagulant control. J clin pathol 38:133–134
Standardisation (1983) World Health organization Expert Committee on Biological Standardization. Thirty third report. Technical report series 687. WHO, Geneva, pp 81–105
BCSH (1998) Guidelines on oral anticoagulation: third edition. Br J Haematol 101:374–387
Beeser H (1988) Critical evaluation of the so far experience using the WHO model of prothrombin time calibration and outlook for further development. Haemostasis 18:181–182
Dalen JE, Hirsh J (1995) ACCP 4th Consensus conference introduction. Chest 108:225–265
Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, De Rosa L, Hamilton S, Ragg P, Robinson S, Auldist A, Crock C, Roy N, Rowlands S (2006) Developmental haemostasis: impact for clinical haemostasis laboratories. Thromb Haemost 95:362–372
Adcock DM, Kressin DC, Marlar RA (1997) Effect of 3.2% vs. 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 107:105–110
Duncan EM, Casey CR, Duncan BM, Lloyd JV (1994) Effect of concentration of trisodium citrate anticoagulant on the calculation of the International Normalised Ratio and the International Sensitivity Index of thromboplastin. Thromb Haemost 72:84–88
van den Besselaar AM (1993) International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing. J Heart Valve Dis 2:42–52
Cunningham MT, Jonhnson GF, Pennell BJ, Olson JD (1994) The reliability of manufacturer-determined, instrument specific international sensitivity index values for calculating the international normalized ratio. Am J Clin Pathol 102:128–133
Craig S, Stevenson KJ, Dufty JM, Taberner DA (1997) Local INR correction: justification for a simplified approach. J Clin Pathol 50:783–789
Talstad I (2000) Why is the standardization of prothrombin time a problem? Haemostasis 30:258–267
Harenberg J, Reichel T, Malsch R, Hirsh J, Rustagi P (1996) Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor. Blood Coagul Fibrinolysis 7:453–458
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70:165–172
Andrew M, Paes B, Milner R, Jonston M, Mitchell L, Tollefsen D, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72:1651–1657
Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998–2005
Miller SP, Sanchez-Avalmods J, Stefanski T, Zuckerman L (1967) Coagulation disorders in cancer. I. Clinical and laboratory studies. Cancer 20:1452–1465
Gordon EM, Ratnoff OD, Jones PK (1982) The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives. J Lab Clin Med 99:363–369
Van Cott EM, Laposata M (2001) Coagulation. In: Jacobs DS, De Mott WR, Oxley DK (eds) Laboratory test handbook, 5th edn. Lexi-Comp, Hudson, OH, pp 327–358
Plebani M, Carraro P (1997) Mistakes in a stat laboratory: types and frequency. Clin Chem 43:1348–1351
Palmer RN, Gralnick HR (1985) Inhibition of cold-promoted activation of the prothrombin time. Studies of new siliconized borosilicate collection tubes in normals and patients receiving warfarin. Am J Clin Pathol 83:492–494
NCCLS (1998) Collection, transport and processing of blood specimens for coagulation testing and general performance of coagulation assays. In: Standards NCCL (ed) 3rd edn, NCCLS, 940 West Valley Road, Wayne, Pennsylvania 19087, USA.
Reneke J, Etzell J, Leslie S (1998) Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol 109:754–757
Ansell J, Becker R, Becker D, Triplett DA, Cimini C, La Duca F (1995) Accurate and precise prothrombin time measurement in a multicenter anticoagulation trial employing patient self-testing. Blood 86:864a
Ignjatovic V, Barnes C, Newall F, Hamilton S, Burgess J, Monagle P (2004) Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek and thrombotest methods with venous international normalised ratio. Thromb Haemost 92:734–737
Wiwanitkit V (2002) Rejection of specimens for prothrombin time and relating pre-analytical factors in blood collection. Blood Coagul Fibrinolysis 13:371–372
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this protocol
Cite this protocol
Ignjatovic, V. (2013). Prothrombin Time/International Normalized Ratio. In: Monagle, P. (eds) Haemostasis. Methods in Molecular Biology, vol 992. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-339-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-339-8_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-338-1
Online ISBN: 978-1-62703-339-8
eBook Packages: Springer Protocols